Comparison of Hormone Receptor Status in Primary and Recurrent Breast Cancer

1 Coffee and caffeine intake and breast cancer risk: An updated dose-response meta-analysis of 37 published studies Gynecologic Oncology, May 10, 2013    Evidence Based Medicine

2 Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study The Lancet Oncology, April 18, 2013

3 Which strategies reduce breast cancer mortality most? Cancer, April 30, 2013

4 Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial European Journal of Cancer, April 19, 2013

5 Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: Results from the HERA Trial Journal of Clinical Oncology, April 25, 2013

6 Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study Journal of Clinical Oncology, April 29, 2013

7 Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma Annals of Oncology, May 6, 2013

8 Plasma Vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies Medicine, May 14, 2013

9 Association Between Metformin Therapy and Mortality After Breast Cancer: A Population-Based Study Diabetes Care, May 2, 2013

10 Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer Annals of Oncology, May 14, 2013